Omicron strain demands new terminology to describe vaccination status against SARS-CoV-2 infection
Recent papers1-3 have demonstrated and confirmed that the omicron variant of SARS-CoV-2, which is now the dominant strain worldwide, is resistant to neutralising vaccinations, and that immunity from two vaccinations is poor. On the other hand, it increases substantially after a third administration. Garcia-Beltran and his colleagues1 state that, in a study of 239 vaccinees internationally, “…Taken together, our results indicate that two-dose mRNA-based vaccines are effective at inducing neutralizing immunity to SARS-CoV-2 wild-type and Delta variants but suboptimal for inducing neutralizing responses to the Omicron variant” but that “…recently boosted vaccinees exhibited potent neutralization of Omicron variant pseudovirus that was only moderately decreased relative to wild-type neutralization.” These conclusions are clearly shown in the published graphs. A second in an as yet unpublished paper in Nature from France and Belgium shows the same pattern of immune responses of Omicron, and the same conclusions were drawn. The third community based